Status:
COMPLETED
Dynamic Respiratory Muscle Strength and Endurance in Childhood Asthma
Lead Sponsor:
Bartın Unıversity
Collaborating Sponsors:
Hacettepe University
Conditions:
Asthma in Children
Eligibility:
All Genders
6-11 years
Brief Summary
Peak inspiratory flow (PIF) may be due to respiratory muscle strength, especially in those with severe airflow obstruction. PIF appears to be lower in children and adolescents with asthma than in non-...
Detailed Description
Asthma prevalence is high in childhood and adolescence and the disease imposes an economic burden. In studies, patients with peak inspiratory flow (PIF) showed variability in severe obstruction and a ...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Asthmatic Group Research:
- Hacettepe University Faculty of Medicine, Department of Pediatrics, Allergy and Asthma Unit patients referred for Cardiopulmonary Rehabilitation,
- Those who have been diagnosed with asthma,
- Clinically stable and not in active asthma attack,
- Between the ages of 6-11,
- Giving consent on a voluntary basis,
- cooperative,
- Asthmatic Group
Exclusion
- Those whose clinical status is not stable and who are in active asthma attack,
- Having serious diseases such as cancers, heart failure and acute respiratory infections,
- Having chronic lung disease other than asthma,
- Severe neuromuscular and musculoskeletal problems,
- Uncooperative to do the tests,
- For safety reasons, patients admitted or hospitalized in the last 3 months due to an asthma attack will not be included in the study.
- Healthy Group Inclusion Criteria:
- Not having any chronic disease for healthy individuals,
- be between the ages of 6-11,
- Volunteering to participate in the study,
- Not having speech and hearing problems,
- Being cooperative,
- Not having a mental, neurological, orthopedic, cardiovascular or pulmonary problem that would prevent physical activity,
- Healthy Group
Key Trial Info
Start Date :
March 13 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06053905
Start Date
March 13 2023
End Date
March 10 2024
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ebru Çalik Kütükcü
Ankara, Altındağ, Turkey (Türkiye), 06100